QUIBIM
Companies will shed light on immunotherapy, an emerging therapeutic approach that helps the immune system fight cancer, in a brand-new study on one of the most impacting cancers worldwide.
The AI-integrated software can be used for early detection of COVID-19 and other diseases through imaging biomarkers in Europe.